Title : Tackling Elevated Risk in PAD: Focus on Antithrombotic and Lipid Therapy for PAD.

Pub. Date : 2020 Jan 29

PMID : 31997026






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The THEMIS trial showed a 55% risk reduction for MALE with ticagrelor DAPT compared with aspirin monotherapy (HR 0.45, 95% CI 0.23-0.86). ticagrelor thymocyte selection associated Homo sapiens